Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT01860456
Eligibility Criteria:
Inclusion Criteria:
* Patients affected by chronic myeloid leukemia
* Age limits: 18-80 years
* Male and female patients
* Treatment with imatinib/nilotinib since at least 3 weeks
* Optimal adherence
* Signed informed consent
Exclusion Criteria:
* Age \<18 or \>80 years
* Poor adherence
* Inability to attend follow-up visits
* Lack of signed informed consent
Concomitant administration of other drugs will be allowed, but active pharmacological agents, their dose and duration of treatment should be recorded.
Smoking is not considered an exclusion criterium, but it should be noticed and recorded
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01860456
Study Brief:
Protocol Section:
NCT01860456